Tackling a Serious Global Threat
Antimicrobial resistance is one of the world’s most serious health threats.
At Entasis, we are working to develop novel antibacterials to treat serious drug-resistant bacterial infections.
Around the world, it is increasingly recognized that antibiotic resistance is a growing public health threat. The development of new antibiotic therapies is not keeping pace with the rise of antibiotic resistance and some life-threatening infections cannot be successfully treated with existing medicines. The World Health Organization (WHO) said this threat is “no longer a prediction for the future, it is happening right now in every region of the world and has the potential to affect anyone.”
A Targeted Approach to Antibiotics
Our targeted strategy is based on our understanding of the mechanisms of antibiotic resistance within specific bacterial pathogens, and discovering novel molecules to overcome this resistance and successfully treat the pathogen.